Prospective Randomized Clinical Trial Evaluating the Impact of Vinegar on High Density Lipoprotein

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE1

Total Enrollment

114 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-06-30

Study Completion Date

2010-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a double-blinded randomized placebo controlled prospective clinical trial evaluating the impact of apple cider vinegar on serum HDL. 112 participants will be randomized to consume either 2 tablespoons of vinegar daily or a placebo containing a 2% balsamic vinegar solution in water. Baseline, two month and 4 month blood samples will be obtained for fasting lipids. The primary endpoint is met if HDL levels increase in the treatment arm versus baseline after 2 month intervention.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cholesterol, HDL

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Participants Investigators

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Vinegar

Apple cider vinegar 2 TBlsp/day

Intervention Type DIETARY_SUPPLEMENT

Placebo

Water placebo colored with balsamic vinegar

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Those older than 18 years of age
* Park Nicollet Health Services patient

Exclusion Criteria

* Because of a potential positive effect of vinegar on improving diabetes mellitus8 and the subsequent change in medication regime for diabetes diabetic patients will be excluded from this study. If this study finds that vinegar does increase HDL levels, a subsequent study of diabetic patients will be conducted.
* History of allergy to apple cider vinegar
* Those with a terminal illness
* Diagnosis of Inflammatory bowel disease
* Those with Immunosuppression diseases
* Patients on dialysis
* Severe psychiatric illness who are unable to consent or reliably participate
* No evidence of end stage renal disease
* Those who use alcohol greater than or equal to 2 drinks per day
* Those who take in \>3 tsp vinegar/day supplement
* Plans to increase exercise or begin diet during the protocol period
* Any use of niacin or niacin-like compounds
* Initiation of niacin, fibrates (eg gemfibrozil); statin or ezetimibe medication within the last 6 weeks or during the trial
* Inability to read English
* Age less than 18 years given clinical events would be unlikely in this population
* LDL greater than 160mg/dL and requires adjustment or addition of statin therapy (which could reduce HDL)
* History of liver failure in medical history review
* Current smoking (as this can reduce HDL levels and it would be unethical to require people to continue smoking during the study)

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Park Nicollet Heart and Vascular Center/Park Nicollet Institute

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Park Nicollet Health Services

Minneapolis, Minnesota, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

03635-07-C

Identifier Type: -

Identifier Source: org_study_id